Cargando…

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma

Gene expression profiling revealed ADAM9 to be distinctly overexpressed in pancreatic ductal adenocarcinoma (PDAC). We examined the relevance of ADAM9 expression in PDAC diagnosis and prognosis. A total of 59 infiltrating PDACs, 32 specimens from patients with chronic pancreatitis, 11 endocrine tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grützmann, R, Lüttges, J, Sipos, B, Ammerpohl, O, Dobrowolski, F, Alldinger, I, Kersting, S, Ockert, D, Koch, R, Kalthoff, H, Schackert, H K, Saeger, H D, Klöppel, G, Pilarsky, C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409625/ https://www.ncbi.nlm.nih.gov/pubmed/14997207 http://dx.doi.org/10.1038/sj.bjc.6601645

Ejemplares similares

Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells
por: Ammerpohl, O, et al.
Publicado: (2007)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

Examination of Apoptosis Signaling in Pancreatic Cancer by Computational Signal Transduction Analysis
por: Rückert, Felix, et al.
Publicado: (2010)

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
por: Suzuoki, M, et al.
Publicado: (2002)

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
por: Boland, G P, et al.
Publicado: (2004)

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004)

Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells
por: Trauzold, A, et al.
Publicado: (2003)

Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
por: Distler, Marius, et al.
Publicado: (2013)

Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast
por: Boland, G P, et al.
Publicado: (2003)

Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence
por: Coradini, D, et al.
Publicado: (2002)

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast
por: Teo, N B, et al.
Publicado: (2002)

Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer
por: Kronqvist, P, et al.
Publicado: (2002)

Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling
por: Pilarsky, Christian, et al.
Publicado: (2008)

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry
por: Korsching, E, et al.
Publicado: (2004)

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells
por: Schwarz, V A, et al.
Publicado: (2002)

Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer
por: Hardt, P D, et al.
Publicado: (2004)

Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade
por: Altura, R A, et al.
Publicado: (2003)

DNA replication licensing and cell cycle kinetics of oligodendroglial tumours
por: Wharton, S B, et al.
Publicado: (2004)

Prognostic impact of chromosomal aberrations in Ewing tumours
por: Hattinger, C M, et al.
Publicado: (2002)

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence
por: Jirström, K, et al.
Publicado: (2003)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells
por: Liu, D, et al.
Publicado: (2002)

FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma
por: Miyazaki, T, et al.
Publicado: (2003)

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development
por: Zuidervaart, W, et al.
Publicado: (2003)

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression
por: Krieg, A, et al.
Publicado: (2002)

DNA topoisomerase I and II expression in drug resistantgerm cell tumours
por: Berney, D M, et al.
Publicado: (2002)

Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma
por: Nakajima, M, et al.
Publicado: (2003)

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function
por: Bhat-Nakshatri, P, et al.
Publicado: (2004)

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells
por: Junnikkala, S, et al.
Publicado: (2002)

NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids
por: Jakobsen, A-M, et al.
Publicado: (2003)

Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH)
por: Fiegl, M, et al.
Publicado: (2004)

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis
por: Thomasson, M, et al.
Publicado: (2003)

Heterogeneity of O(6)-alkylguanine DNA-alkyltransferase expression in human breast tumours
por: Clemons, M J, et al.
Publicado: (2002)

A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer
por: Van Trappen, P O, et al.
Publicado: (2002)

Intra-tumoural microvessel density in human solid tumours
por: Hasan, J, et al.
Publicado: (2002)

Additive interaction of gefitinib (‘Iressa’, ZD1839) and ionising radiation in human tumour cells in vitro
por: Giocanti, N, et al.
Publicado: (2004)

Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas
por: Yan, Y, et al.
Publicado: (2004)

Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage
por: Pardo, F S, et al.
Publicado: (2004)

Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?
por: Handgretinger, R, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_0rmhralfatmjv8hco3btitt8hm